Registry of Asthma Patients Initiating DUPIXENT®
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Clinical Trials Related to Regeneron Pharmaceuticals
Related studies linked through entity extraction aliases.
Observational Study of Conjunctivitis in the Setting of DUPIXENT® Treatment for Atopic Dermatitis
- Status
- COMPLETED
- Phase
- N/A
Dupilumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus
- Status
- COMPLETED
- Phase
- PHASE2
Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC
- Status
- TERMINATED
- Phase
- PHASE2
Evaluate the Efficacy and Safety of Evinacumab in Pediatric Patients With Homozygous Familial Hypercholesterolemia
- Status
- COMPLETED
- Phase
- PHASE3
Open-Label Efficacy and Safety Study of Pozelimab in Patients With CD55-Deficient Protein-Losing Enteropathy (CHAPLE Disease)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Adult Patients With Asthma
- Status
- COMPLETED
- Phase
- PHASE4
Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME)
- Status
- COMPLETED
- Phase
- PHASE3
Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID)
- Status
- COMPLETED
- Phase
- PHASE3
Post-authorization Safety Study in North America to Monitor Pregnancy and Infant Outcomes Following Administration of Dupilumab During Planned or Unexpected Pregnancy
- Status
- COMPLETED
- Phase
- N/A
REGN3918 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate Its Long Term Safety, Efficacy and Tolerability.
- Status
- TERMINATED
- Phase
- PHASE3
Study of REGN4461, a Leptin Receptor Agonist Antibody, in Patients With Generalized Lipodystrophy
- Status
- COMPLETED
- Phase
- PHASE2
Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Dupilumab and Milk OIT for the Treatment of Cow's Milk Allergy
- Status
- TERMINATED
- Phase
- PHASE2
Safety, Tolerability, and Efficacy of Aflibercept in Patients With Neovascular Age-Related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE2
Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity
- Status
- COMPLETED
- Phase
- PHASE3
First In Human (FIH) Study of REGN5459 in Adult Patients With Relapsed or Refractory Multiple Myeloma (MM)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2